Jonathan Nkalubo

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

James Hakim, Cissy Kityo, Anne Hoppé et al. · The Lancet Infectious Diseases · 2017 · 41 citations · Full text

Pharmacy, Infectious Disease Control, Pharmacotherapy +17

High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy

Ravindra K. Gupta, Ruth Goodall, Michael Rañopa et al. · Clinical Infectious Diseases · 2013 · 38 citations · Full text

Pharmacy, Pharmacotherapy, Hiv Control +16

Research involvement among undergraduate health profession students in a resource-limited setting: awareness, attitude, motivators and barriers

Blaise Kiyimba, Linda Atulinda, Racheal Nalunkuma et al. · BMC Medical Education · 2022 · 24 citations · Full text

Public Health, Health Education, Medical Education +8

Knowledge on Infection Prevention and Control and associated factors among undergraduate health professional students at Makerere University College of Health Sciences, Uganda

Racheal Nalunkuma, Jonathan Nkalubo, Derrick Bary Abila · PLoS ONE · 2021 · 18 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +17

Policy responses to COVID-19 in Sri Lanka and the consideration of Indigenous Peoples

Eranga K. Galappaththi, Chrishma D. Perera, Indunil P. Dharmasiri et al. · Environmental Science & Policy · 2023 · 13 citations · Full text

Law, Health Policy, Infectious Diseases +15